INOVIO PHARMACEUTICALS, INC. (INO) › RevenueINOVIO PHARMACEUTICALS, INC. (INO) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $35.37M2017: $42.22M2018: $30.48M2019: $4.11M2020: $7.41M2021: $1.77M2022: $10.26M2023: $832.0K2024: $217.8K2025: $65.3K$65.3K2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$65.3K-70.0%2024$217.8K-73.8%2023$832.0K-91.9%2022$10.26M+478.2%2021$1.77M-76.1%2020$7.41M+80.2%2019$4.11M-86.5%2018$30.48M-27.8%2017$42.22M+19.4%2016$35.37M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share